Researchers identify what drives PARP inhibitor resistance in advanced breast cancer 08 May 2024 Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease. Find out more Show/Hide
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer 02 May 2024 Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body. Find out more Show/Hide
ICR researcher wins prestigious clinical science award 25 Apr 2024 Dr Stephen-John Sammut, a Clinician Scientist at the ICR, and Consultant in Medical Oncology at The Royal Marsden, has been awarded the Graham Bull Prize by the Royal College of Physicians for his work in personalised breast cancer medicine. Find out more Show/Hide